Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons
Nonsense mutations that generate a premature termination codon (PTC) can induce both the accelerated degradation of mutated mRNA compared with the wild type version of the mRNA or the production of a truncated protein. One of the considered therapeutic strategies to bypass PTCs is their “readthrough...
Main Authors: | Nesrine Benslimane, Camille Loret, Pauline Chazelas, Frédéric Favreau, Pierre-Antoine Faye, Fabrice Lejeune, Anne-Sophie Lia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/3/314 |
Similar Items
-
Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot–Marie–Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in <i>GDAP1</i> Gene
by: Nesrine Benslimane, et al.
Published: (2023-07-01) -
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
by: Shan Li, et al.
Published: (2023-06-01) -
Poly(A)-Binding Protein Regulates the Efficiency of Translation Termination
by: Chan Wu, et al.
Published: (2020-11-01) -
Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
by: Renata B. V. Abreu, et al.
Published: (2022-06-01) -
Rescue of nonsense mutations by amlexanox in human cells
by: Gonzalez-Hilarion Sara, et al.
Published: (2012-08-01)